“In people who have diabetes, when they’re on GLP-1s, they experience an early increase in the risk of diabetic retinopathy,” ...

Glass tried the injections for his advanced disease, but they did not halt his vision loss. So his ophthalmologist tried ...

David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...

Toowoomba needs and deserves a public eye unit as part of the new Toowoomba Hospital so elderly patients no longer need to be ...

Eydenzelt is a vascular endothelial growth factor inhibitor referencing Eylea, which is jointly developed by Regeneron ...

Hospitalized patients with diabetes require specialized management to reduce readmission rates and complications. Newer ...

Otsuka Pharmaceuticals could shell out over $400 million in total for the Asia-Pacific rights to 4D-150, which combines a ...

Scientists have discovered that human stomach cells can be genetically reprogrammed to act like pancreatic beta cells and produce insulin. This approach could one day help people with Type 1 diabetes ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide.

Millions in India face silent vision loss from diabetic retinopathy, a serious complication of diabetes. High blood sugar ...

4D Molecular Therapeutics has sold the Asia-Pacific rights to its eye gene therapy to Otsuka Pharmaceutical, securing $85 ...

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...